Related Experiment Video

Updated: May 17, 2026

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
07:00

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas

Published on: February 28, 2019

The Role of EGFR and HER2- Activating Mutations in Maxillary Sinus Cancer

Patricia Ene1, Radu Cristian Popescu, Stefan Voiculescu

  • 1Emergency University Hospital, Bucharest, E.N.T. Department.

Maedica
|November 3, 2012
PubMed

Insights

This study discusses novel therapies for sinonasal cancer, focusing on targeted agents and multimodal approaches. Biomarkers are crucial for assessing disease progression and patient survival rates.

Area of Science:

  • Oncology
  • Cancer Research

Background:

  • Sinonasal squamous cell carcinomas are rare but aggressive tumors.
  • Their location near critical structures necessitates complex treatment strategies.

Purpose of the Study:

  • To review recent advancements in sinonasal cancer management.
  • To explore the role of targeted therapies and multimodal approaches.
  • To discuss the utility of biomarkers in predicting prognosis.

Main Methods:

  • Literature review of novel agents targeting EGF receptor (EGFR), VEGF, and p53 pathways.
  • Analysis of multimodal therapy development.
  • Evaluation of biomarker applications in clinical practice.

Main Results:

  • Emerging targeted agents show promise for sinonasal cancer treatment.
  • Multimodal strategies are essential for optimal outcomes.
  • Biomarkers are key to understanding disease progression and survival.

Conclusions:

  • Novel targeted therapies and multimodal approaches represent the future of sinonasal cancer management.
  • Further research is needed to fully analyze the clinical utility of EGFR overexpression and other biomarkers.
Keywords:
EGFRhead and neck cancersoverexpressionsinonasal cancer

More Related Videos

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...